PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Market and Technology Update, page-121

  1. 4,149 Posts.
    The inactivity ,huge cash burn , a failed Eap and licensing failures did it for me.
    That an the ineffectiveness of the new directors.
    Death spiral or not they will run out of cash and and potential licensee will draw out a deal knowing management will get more desperate....assuming there is anyone even interested.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.